Skip to main content
SpringerLink
Log in
Book cover

Ischemic Optic Neuropathies pp 389–415Cite as

Management of Non-arteritic Anterior Ischemic Optic Neuropathy

  • Chapter
  • First Online:

  • 1305 Accesses

Abstract

Non-arteritic anterior ischemic optic neuropathy (NA-AION) is a major cause of seriously impaired vision among the middle-aged and elderly population; in addition, contrary to popular belief, it also occurs in young persons, though less commonly. Nevertheless, almost all publications on NA-AION contain the ­following two statements:

For a complete bibliography and detailed review of previously published studies in the literature on the subject, please refer to bibliography in previous publications listed here.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55(1):47–63.

    Article  PubMed  Google Scholar 

  2. Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol. 1989;107(12):1743–54.

    PubMed  CAS  Google Scholar 

  3. Hayreh SS. The role of optic nerve sheath fenestration in management of anterior ischemic optic neuropathy. Arch Ophthalmol. 1990;108(8):1063–5.

    PubMed  CAS  Google Scholar 

  4. Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol. 1964;48:522–43.

    Article  PubMed  CAS  Google Scholar 

  5. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol. 1977;95(9):1553–65.

    PubMed  CAS  Google Scholar 

  6. Hayreh SS. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol. 1977;95(9):1566–79.

    PubMed  CAS  Google Scholar 

  7. Hayreh SS. The sheath of the optic nerve. Ophthalmologica. 1984;189(1–2):54–63.

    Article  PubMed  CAS  Google Scholar 

  8. Hayreh SS. Anterior ischaemic optic neuropathy. III. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol. 1974;58(12):981–89.

    Article  PubMed  CAS  Google Scholar 

  9. Heidemann SR, Kaufman D. Axonal transport and anterior ischemic optic neuropathy. Arch Ophthalmol. 1991;109(7):916–7.

    PubMed  CAS  Google Scholar 

  10. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273(8):625–32.

    Article  Google Scholar 

  11. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008;115(2):298–305.

    Article  PubMed  Google Scholar 

  12. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246(7):1029–46.

    Article  PubMed  CAS  Google Scholar 

  13. Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2007;114(9):1763–72.

    Article  PubMed  Google Scholar 

  14. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115(10):1818–25.

    Article  PubMed  Google Scholar 

  15. Flaharty PM, Sergott RC, Lieb W, Bosley TM, Savino PJ. Optic nerve sheath decompression may improve blood flow in anterior ischemic optic neuropathy. Ophthalmology. 1993;100(3):297–302. discussion 303–295.

    PubMed  CAS  Google Scholar 

  16. Hayreh SS, Beach KW. Optic nerve sheath decompression may improve blood flow in anterior ischemic optic neuropathy: discussion. Ophthalmology. 1993;100(3):303–5.

    Google Scholar 

  17. Manor RS. Nonarteritic ischemic optic neuropathy in identical female twins: improvement of visual outcome in one by optic nerve decompression. Arch Ophthalmol. 1990;108(8):1067–8.

    PubMed  CAS  Google Scholar 

  18. Kelman SE, Elman MJ. Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol. 1991;109(5):667–71.

    PubMed  CAS  Google Scholar 

  19. Spoor TC, Wilkinson MJ, Ramocki JM. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1991;111(6):724–8.

    PubMed  CAS  Google Scholar 

  20. Spoor TC, McHenry JG, Lau-Sickon L. Progressive and static nonarteritic ischemic optic neuropathy treated by optic nerve sheath decompression. Ophthalmology. 1993;100(3):306–11.

    PubMed  CAS  Google Scholar 

  21. Jablons MM, Glaser JS, Schatz NJ, Siatkowski RM, Tse DT, Kronish JW. Optic nerve sheath fenestration for treatment of progressive ischemic optic neuropathy. Results in 26 patients. Arch Ophthalmol. 1993;111(1):84–7.

    PubMed  CAS  Google Scholar 

  22. Glaser JS, Teimory M, Schatz NJ. Optic nerve sheath fenestration for progressive ischemic optic neuropathy. Results in second series consisting of 21 eyes. Arch Ophthalmol. 1994;112(8):1047–50.

    PubMed  CAS  Google Scholar 

  23. Yee RD, Selky AK, Purvin VA. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol. 1994;14(2):70–6.

    PubMed  CAS  Google Scholar 

  24. Kelman SE. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: Do they merit further study? J Neuroophthalmol. 2007;27(3):161–3.

    PubMed  Google Scholar 

  25. Hayreh SS. The role of aspirin in non-arteritic anterior ischaemic optic neuropathy. Neuro-Ophthalmol. 2010;34(1):1–5.

    Article  Google Scholar 

  26. Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol. 1981;38(11):675–8.

    PubMed  CAS  Google Scholar 

  27. Hayreh SS. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol. 1985;59(3):217–46.

    Article  PubMed  CAS  Google Scholar 

  28. Hayreh SS. Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am. 1996;9(3):407–42.

    Google Scholar 

  29. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34–62.

    Article  PubMed  Google Scholar 

  30. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand. 2002;80(4):355–67.

    Article  PubMed  Google Scholar 

  31. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–15.

    Article  PubMed  Google Scholar 

  32. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123(2):212–7.

    PubMed  CAS  Google Scholar 

  33. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134(3):317–28.

    Article  PubMed  Google Scholar 

  34. Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol. 1997;124(5):641–7.

    PubMed  CAS  Google Scholar 

  35. Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil. 2005;12(1):75–81.

    Article  PubMed  Google Scholar 

  36. Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology. 2007;114(4):804–9.

    Article  PubMed  Google Scholar 

  37. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999;106(4):739–42.

    Article  PubMed  CAS  Google Scholar 

  38. Abu-Amero KK, Bosley TM. Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations. Br J Ophthalmol. 2006;90(1):119–20.

    Article  PubMed  CAS  Google Scholar 

  39. Hayreh SS. Non-arteritic anterior ischemic optic neuropathy and thrombophilia. Graefes Arch Clin Exp Ophthalmol. 2009;247(5):577–81.

    Article  PubMed  Google Scholar 

  40. Bull GM. Meteorological correlates with myocardial and cerebral infarction and respiratory disease. Br J Prev Soc Med. 1973;27(2):108–13.

    PubMed  CAS  Google Scholar 

  41. Bull GM, Morton J. Environment, temperature and death rates. Age Ageing. 1978;7(4):210–24.

    Article  PubMed  CAS  Google Scholar 

  42. Clark CV. Seasonal variation in incidence of brachial and femoral emboli. Br Med J (Clin Res Ed). 1983;287(6399):1109.

    Article  CAS  Google Scholar 

  43. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118(6):766–80.

    PubMed  CAS  Google Scholar 

  44. Kosmorsky G, Straga J, Knight C, Dagirmanjian A, Davis DA. The role of transcranial Doppler in nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1998;126(2):288–90.

    Article  PubMed  CAS  Google Scholar 

  45. Stiebel-Kalish H, Hasanreisoglu M, Leibovici L. Aspirin following non-arteritic ischaemic optic neuropathy: a systematic review and meta-analysis. Neuro-Ophthalmology. 2010;34(1):14–9.

    Article  Google Scholar 

  46. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol. 1997;17(4):250–3.

    PubMed  CAS  Google Scholar 

  47. Salomon O, Huna-Baron R, Steinberg DM, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 1999;13(Pt 3a):357–9.

    Google Scholar 

  48. Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy (Correspondence). Eye (Lond). 2000;14(Pt 1):118.

    Google Scholar 

  49. Johnson LN, Gould TJ, Krohel GB. Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months’ duration. Am J Ophthalmol. 1996;121(1):77–83.

    PubMed  CAS  Google Scholar 

  50. Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107(3):521–6.

    Article  PubMed  CAS  Google Scholar 

  51. Beck RW. Does Levodopa improve visual function in NAION? Ophthalmology. 2000;107(8):1431–4.

    Article  PubMed  CAS  Google Scholar 

  52. Hayreh SS. Does Levodopa improve visual function in NAION? Ophthalmology. 2000;107(8):1434–8.

    Article  PubMed  CAS  Google Scholar 

  53. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140(3):376–91.

    Article  PubMed  Google Scholar 

  54. Miller GR, Smith JL. Ischemic optic neuropathy. Am J Ophthalmol. 1966;62(1):103–15.

    PubMed  CAS  Google Scholar 

  55. Foulds WS. Visual disturbances in systemic disorders. Optic neuropathy and systemic disease. Trans Ophthalmol Soc UK. 1969;89:125––146.

    Google Scholar 

  56. Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(8):1107–21.

    Article  PubMed  Google Scholar 

  57. Hayreh SS. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Surv Ophthalmol. 2010;55(4):399–400.

    Article  PubMed  Google Scholar 

  58. Biousse V, Bruce BB, Newman NJ. Non-arteritic anterior ischemic optic neuropathy. Role of systemic corticosteroid therapy. Surv Ophthalmol. 2010;55(4):400–1.

    Article  Google Scholar 

  59. Lee AG, Biousse V. Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol. 2010;30(2):193–8.

    PubMed  Google Scholar 

  60. Hayreh SS. Role of steroid therapy in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2010;30(4):388.

    PubMed  Google Scholar 

  61. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969;53(11):721–48.

    Article  PubMed  CAS  Google Scholar 

  62. Hayreh SS. The 1994 Von Sallman lecture: the optic nerve head circulation in health and disease. Exp Eye Res. 1995;61(3):259–72.

    Article  PubMed  CAS  Google Scholar 

  63. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res. 2001;20(5):563–93.

    Article  PubMed  CAS  Google Scholar 

  64. Hayreh SS. Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol. 1978;23(1):1–25.

    Article  PubMed  CAS  Google Scholar 

  65. McLeod D, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol. 1980;64(4):247–61.

    Article  PubMed  CAS  Google Scholar 

  66. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX Cup disc ratio role pathogenesis. Ophthalmology. 1987;94(11):1503–8.

    PubMed  CAS  Google Scholar 

  67. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: refractive error and its relationship to cup/disc ratio. Ophthalmology. 2008;115(12):2275–81.

    Article  PubMed  Google Scholar 

  68. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117(5):603–24.

    PubMed  CAS  Google Scholar 

  69. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213(2):76–96.

    Article  PubMed  CAS  Google Scholar 

  70. Kaur C, Foulds WS, Ling EA. Blood–retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6)):622–47.

    Article  PubMed  CAS  Google Scholar 

  71. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW. Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol. 1998;27((3):163–73.

    Article  Google Scholar 

  72. Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol. 2004;187(2):388–402.

    Article  PubMed  CAS  Google Scholar 

  73. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: fundamentals and clinical practice. St Louis: Mosby; 1996.

    Google Scholar 

  74. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595–624.

    Article  PubMed  CAS  Google Scholar 

  75. Jonas JB, Spandau UH, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):749–50.

    Article  PubMed  CAS  Google Scholar 

  76. Kaderli B, Avci R, Yucel A, Guler K, Gelisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27(3):164–8.

    PubMed  Google Scholar 

  77. Hayreh SS. Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2008;28(1):77–8. author reply 78–9.

    PubMed  Google Scholar 

  78. Sarraf D, Vyas N, Jain A, Bui A, Kertes PJ, Freund KB, et al. Triamcinolone-associated crystalline maculopathy. Arch Ophthalmol. 2010;128(6):685–90.

    Article  PubMed  CAS  Google Scholar 

  79. Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007;27(3):238–40.

    PubMed  Google Scholar 

  80. Pece A, Querques G, Quinto A, Isola V. Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy. J Ocul Pharmacol Ther. 2010;26(5):523–7.

    Article  PubMed  CAS  Google Scholar 

  81. Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol. 2009;29(2):160–1.

    PubMed  Google Scholar 

  82. Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1707–10.

    Article  PubMed  CAS  Google Scholar 

  83. Hayreh SS. Anterior ischemic optic neuropathy. V. Optic disc edema an early sign. Arch Ophthalmol. 1981;99(6):1030–40.

    PubMed  CAS  Google Scholar 

  84. Hayreh SS. Management of non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1595–600.

    Article  PubMed  Google Scholar 

  85. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol. 2008;246(1):81–7.

    Article  PubMed  CAS  Google Scholar 

  86. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management. Eye (Lond). 2004;18(11):1188–206.

    CAS  Google Scholar 

  87. Hayreh SS. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: Is there a cause and effect relationship? J Neuroophthalmol. 2005;25(4):295–8.

    PubMed  Google Scholar 

  88. Hayreh SS. Non-arteritic anterior ischaemic optic neuropathy and phosphodiesterase-5 inhibitors. Br J Ophthalmol. 2008;92(12):1577–80.

    Article  PubMed  Google Scholar 

  89. Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128(3):301–9.

    Article  PubMed  CAS  Google Scholar 

  90. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94(8)):1020–8.

    PubMed  CAS  Google Scholar 

  91. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132(5):734–42.

    Article  PubMed  CAS  Google Scholar 

  92. Pathak A, Raoul V, Montastruc JL, Senard JM. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur J Clin Pharmacol. 2005;61(5–6):471–4.

    Article  PubMed  CAS  Google Scholar 

  93. Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F. Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets. 2007;7(1):63–70.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, University of Iowa Hospital and Clinics College of Medicine, Hawkins Dr. 200, Iowa City, IA, 52242–1091, USA

    Dr. Sohan Singh Hayreh

Authors
  1. Dr. Sohan Singh Hayreh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohan Singh Hayreh .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hayreh, S.S. (2011). Management of Non-arteritic Anterior Ischemic Optic Neuropathy. In: Ischemic Optic Neuropathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11852-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11852-4_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11849-4

  • Online ISBN: 978-3-642-11852-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation